Tumor histology revealed a 3.2-fold increase in CD56+CD16A+ NK cell infiltration in treated tumors, correlating with necrotic areas—a phenomenon analogous to CD16A/CD30 BsAb mechanisms in lymphoma (18, 19). This evidence concerns the gene NCAM1 and neoplasm.